Cell Growth & Differentiation, Vol 8, Issue 10 1071-1082, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas

A Sundaresan, K Claypool, K Mehta, G Lopez-Berestein, F Cabanillas and RJ Ford Jr
Department of Molecular Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

Retinoids have been shown to modulate cell growth and differentiation in a variety of human tumor cell types, but their effects on B-cell non-Hodgkin's lymphomas (NHL-B) have not been explored. In this study, all-trans retinoic acid (ATRA) in the free form and liposome-encapsulated form (L-ATRA) were used to determine effects on fresh NHL-B patient cells as well as cell lines recently established from both HIV-negative and -positive NHL-B patient biopsies. Both ATRA and L-ATRA were found to inhibit cell proliferation in NHL-B cells. However, L-ATRA was found to be superior to free ATRA in inhibiting cell proliferation of NHL-B cells and resulted in greater than 90% cell growth inhibition in a dose-dependent manner. In addition, L-ATRA also induced high levels of apoptosis in NHL-B cells in vitro. To delineate the apoptotic pathways involved, the expression of the apoptosis suppressor oncogene bcl-2 was evaluated in different NHL-B cells with and without the t(14;18) chromosomal translocation. After L-ATRA exposure, more than a 50% reduction in the expression of bcl-2 protein was observed. bcl-2 message levels were also down-regulated in the L-ATRA-sensitive NHL-B cells. Bax protein levels were analyzed and found to be up-regulated in L-ATRA-sensitive NHL-B cells. Similar results were observed in sensitive AIDS/lymphoma cell lines. Experiments using an RAR-alpha antagonist (RO 41-5253) showed that both the proliferation inhibition and apoptosis induced by L-ATRA could be blocked in NHL-B cells. The findings of the present study indicate that L-ATRA may possess therapeutic potential in blocking cell proliferation, inducing apoptosis, and

This article has been cited by other articles:

				H.-J. Zhou, L. V. Pham, A. T. Tamayo, Y.-C. Lin-Lee, L. Fu, L. C. Yoshimura, and R. J. Ford Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma Blood, September 15, 2007; 110(6): 2121 - 2127. [Abstract] [Full Text] [PDF]

				M. Guidoboni, P. Zancai, R. Cariati, S. Rizzo, J. Dal Col, A. Pavan, A. Gloghini, M. Spina, A. Cuneo, F. Pomponi, et al. Retinoic Acid Inhibits the Proliferative Response Induced by CD40 Activation and Interleukin-4 in Mantle Cell Lymphoma Cancer Res., January 15, 2005; 65(2): 587 - 595. [Abstract] [Full Text] [PDF]

				A. Bowman, D. Jones, L. J. Medeiros, and R. Luthra Quantitative PCR Detection of t(14;18) bcl-2/JH Fusion Sequences in Follicular Lymphoma Patients: Comparison of Peripheral Blood and Bone Marrow Aspirate Samples J. Mol. Diagn., November 1, 2004; 6(4): 396 - 400. [Abstract] [Full Text] [PDF]

				L. V. Pham, A. T. Tamayo, L. C. Yoshimura, P. Lo, and R. J. Ford Inhibition of Constitutive NF-{kappa}B Activation in Mantle Cell Lymphoma B Cells Leads to Induction of Cell Cycle Arrest and Apoptosis J. Immunol., July 1, 2003; 171(1): 88 - 95. [Abstract] [Full Text] [PDF]

				S. K. Cheema, S. K. Mishra, V. M. Rangnekar, A. M. Tari, R. Kumar, and G. Lopez-Berestein Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter J. Biol. Chem., May 23, 2003; 278(22): 19995 - 20005. [Abstract] [Full Text] [PDF]